Chlamydia trachomatis Antibody (IgM)
Use
Chlamydia trachomatis is associated with infections of the mucous membranes of the urogenital system, the upper respiratory tract, and the eye. The usefulness of serologic tests depends on the site of infection, duration of disease, infecting serovars and previous exposure to chlamydial antigens. Because C. trachomatis is ubiquitous, there is a high prevalence of antibodies in sexually active populations. Individuals may be reinfected and IgM antibodies may not appear. IgG antibodies may persist even after treatment, making assessment of a single IgG titer difficult. Consequently, serological diagnosis is seldom used to diagnose genital tract infections. Instead, Nucleic Acid Amplification Testing (NAAT) or culture should be considered to detect chlamydia trachomatis. Culture can also be used to diagnose infant respiratory infection or conjunctivitis.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL (preferred)
Minimum Volume
0.1 mL
Container
Serum separator tube or red‑top tube (no gel)
Collection Instructions
Collect in a serum separator tube or red‑top tube (no gel). The tube should be centrifuged after clotting. Spun serum separator tubes may be submitted at room temperature or refrigerated unopened without transfer to a plastic screw‑cap vial. Red‑top tube (no gel) serum should be transferred to a plastic screw‑cap vial and submitted for testing.
Causes for Rejection
Gross hemolysis • Grossly lipemic • Grossly icteric • Samples submitted in original red‑top tube (no gel)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
